Michael J. Peluso, M.D. - Publications

Affiliations: 
2013 Medicine Yale University, New Haven, CT 
Area:
Medicine and Surgery, Neuroscience Biology, General

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Reeves DB, Rigau DN, Romero A, Zhang H, Simonetti FR, Varriale J, Hoh R, Zhang L, Smith KN, Montaner LJ, Rubin LH, Gange SJ, Roan NR, Tien PC, Margolick JB, ... Peluso MJ, et al. Mild HIV-specific selective forces overlaying natural CD4+ T cell dynamics explain the clonality and decay dynamics of HIV reservoir cells. Medrxiv : the Preprint Server For Health Sciences. PMID 38405967 DOI: 10.1101/2024.02.13.24302704  0.306
2023 Marquez NG, Jamal A, Johnston R, Richter EI, Gorbach PM, Vannorsdall TD, Rubin LH, Jennings CL, Landay AL, Peluso MJ, Antar AAR. Characterizing Symptoms and Identifying Biomarkers of Long COVID in People with and without HIV: Protocol for a Remotely-Conducted Prospective Observational Cohort Study. Jmir Research Protocols. PMID 37104709 DOI: 10.2196/47079  0.309
2022 Peluso MJ, Spinelli MA, Deveau TM, Forman CA, Munter SE, Mathur S, Tang AF, Lu S, Goldberg SA, Arreguin MI, Hoh R, Tai V, Chen JY, Martinez EO, Yee BC, et al. Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection. Aids (London, England). PMID 35866847 DOI: 10.1097/QAD.0000000000003338  0.331
2021 Peluso MJ, Hellmuth J, Chow FC. Central Nervous System Effects of COVID-19 in People with HIV Infection. Current Hiv/Aids Reports. 18: 538-548. PMID 34843065 DOI: 10.1007/s11904-021-00582-x  0.344
2021 Collins DR, Urbach JM, Racenet ZJ, Arshad U, Power KA, Newman RM, Mylvaganam GH, Ly NL, Lian X, Rull A, Rassadkina Y, Yanez AG, Peluso MJ, Deeks SG, Vidal F, et al. Functional impairment of HIV-specific CD8 T cells precedes aborted spontaneous control of viremia. Immunity. PMID 34496223 DOI: 10.1016/j.immuni.2021.08.007  0.3
2021 Claytor JD, Viramontes O, Conner S, Wen KW, Beck K, Chin-Hong PV, Henrich TJ, Peluso MJ. TNF-alpha inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines. Aids (London, England). PMID 34115645 DOI: 10.1097/QAD.0000000000002985  0.325
2021 Spinelli MA, Lynch KL, Yun C, Glidden DV, Peluso MJ, Henrich TJ, Gandhi M, Brown LB. SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study. The Lancet. Hiv. PMID 33933189 DOI: 10.1016/S2352-3018(21)00072-2  0.311
2021 Dubé K, Kanazawa J, Dee L, Taylor J, Campbell DM, Brown B, Johnson MO, Saberi P, Sauceda JA, Sugarman J, Peluso MJ. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research. Hiv Research & Clinical Practice. 1-17. PMID 33757411 DOI: 10.1080/25787489.2021.1902116  0.313
2020 Peluso MJ, Bakkour S, Busch MP, Deeks SG, Henrich TJ. A High Percentage of People with HIV on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following COVID-19. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33211091 DOI: 10.1093/cid/ciaa1754  0.321
2020 Jiang C, Lian X, Gao C, Sun X, Einkauf KB, Chevalier JM, Chen SMY, Hua S, Rhee B, Chang K, Blackmer JE, Osborn M, Peluso MJ, Hoh R, Somsouk M, et al. Distinct viral reservoirs in individuals with spontaneous control of HIV-1. Nature. PMID 32848246 DOI: 10.1038/S41586-020-2651-8  0.402
2020 Peluso MJ, Dee L, Shao S, Taylor J, Campbell D, Collins S, Gandhi M, Johnston R, Deeks SG, Sauceda JA, Dubé K. Operationalizing HIV cure-related trials with analytic treatment interruptions during the SARS-CoV-2 pandemic: A collaborative approach. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32841311 DOI: 10.1093/Cid/Ciaa1260  0.42
2020 Ho HE, Peluso MJ, Margus C, Matias Lopes JP, He C, Gaisa MM, Osorio G, Aberg JA, Mullen MP. Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV. The Journal of Infectious Diseases. PMID 32601704 DOI: 10.1093/Infdis/Jiaa380  0.371
2020 Jilg N, Garcia-Broncano P, Peluso M, Segal FP, Bosch RJ, Roberts-Toler C, Chen SMY, Van Dam CN, Keefer MC, Kuritzkes DR, Landay AL, Deeks S, Yu XG, Sax PE, Li JZ, et al. Hiv Controllers Maintain Viral Suppression Despite Waning T-Cell Responses On Art. The Journal of Infectious Diseases. PMID 32496516 DOI: 10.1093/Infdis/Jiaa294  0.406
2020 Ward LM, Peluso MJ, Budak JZ, Elicker BM, Chin-Hong PV, Lampiris H, Mulliken JS. Opportunistic coinfection with and associated with idelalisib treatment in a patient with chronic lymphocytic leukaemia. Bmj Case Reports. 13. PMID 32354764 DOI: 10.1136/Bcr-2019-234113  0.312
2020 Peluso MJ, Chen J, Munter S, Reed A, Teraoka J, Eshun-Wilson I, Henrich TJ, Chin-Hong PV. Outcomes of immunomodulatory and biologic therapy in people living with HIV: a report from two academic hospitals. Aids (London, England). PMID 32310901 DOI: 10.1097/Qad.0000000000002549  0.397
2020 Peluso MJ, Thanh C, Prator CA, Hogan LE, Arechiga VM, Stephenson S, Norris PJ, Di Germanio C, Fuchs D, Zetterberg H, Deeks SG, Gisslén M, Price RW, Henrich TJ. Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1. Journal of Virus Eradication. 6: 19-26. PMID 32175087 DOI: 10.1016/S2055-6640(20)30006-6  0.433
2020 Peluso MJ, Bacchetti P, Ritter KD, Beg SA, Lai J, Martin JN, Hunt PW, Henrich TJ, Siliciano JD, Siliciano RF, Laird GM, Deeks SG. Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy. Jci Insight. PMID 32045386 DOI: 10.1016/S2055-6640(20)30130-8  0.42
2020 Peluso MJ, Colby DJ, Pinyakorn S, Ubolyam S, Intasan J, Trichavaroj R, Chomchey N, Prueksakaew P, Slike BM, Krebs SJ, Jian N, Robb ML, Phanuphak P, Phanuphak N, Spudich S, et al. Liver function test abnormalities in a longitudinal cohort of Thai individuals treated since acute HIV infection. Journal of the International Aids Society. 23: e25444. PMID 31953919 DOI: 10.1002/Jia2.25444  0.621
2020 Peluso MJ, Dee L, Campbell D, Taylor J, Hoh R, Rutishauser RL, Sauceda J, Deeks SG, Dubé K. A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption Journal of Virus Eradication. 6: 34-37. DOI: 10.1016/S2055-6640(20)30009-1  0.393
2019 Prator CA, Thanh C, Kumar S, Pan T, Peluso MJ, Bosch R, Jones N, Milush JM, Bakkour S, Stone M, Busch MP, Deeks SG, Hunt PW, Henrich TJ. Circulating CD30+ CD4+ T Cells Increase Prior to HIV Rebound Following Analytical Antiretroviral Treatment Interruption. The Journal of Infectious Diseases. PMID 31677350 DOI: 10.1093/Infdis/Jiz572  0.383
2019 Peluso MJ, Deeks SG, McCune JM. HIV "cure": A shot in the arm? Ebiomedicine. PMID 30982768 DOI: 10.1016/J.Ebiom.2019.04.011  0.428
2019 Kim SJ, Peluso MJ, Wang Y, Bikle D, Shoback D, Kim S. Rapid onset of hypercalcemia from high-grade lymphoma in the setting of HIV-related immune reconstitution inflammatory syndrome. Bone Reports. 10: 100194. PMID 30627599 DOI: 10.1016/J.Bonr.2018.100194  0.415
2019 Peluso MJ, Eshun-Wilson I, Henrich TJ, Chin-Hong P. 324. Outcomes of Immunomodulatory and Biologic Therapy in People Living with HIV: A Report from Two Academic Hospitals Open Forum Infectious Diseases. 6. DOI: 10.1093/Ofid/Ofz360.397  0.382
2019 Peluso M, Burbelo P, Kumar S, Munter S, Hoh R, Lee S, Hunt P, Rutishauser R, Henrich T, Deeks S. Characterising ‘exceptional’ control among HIV elite controllers Journal of Virus Eradication. 5: 31. DOI: 10.1016/S2055-6640(20)30153-9  0.383
2016 Peluso MJ, Valcour V, Phanuphak N, Ananworanich J, Fletcsher JL, Chalermchai T, Krebs SJ, Robb ML, Hellmuth J, Gisslén M, Zetterberg H, Spudich S. Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection. Aids (London, England). PMID 27819802 DOI: 10.1097/Qad.0000000000001314  0.613
2015 Peluso MJ, Valcour V, Ananworanich J, Sithinamsuwan P, Chalermchai T, Fletcher JL, Lerdlum S, Chomchey N, Slike B, Sailasuta N, Gisslén M, Zetterberg H, Spudich S. Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection. The Journal of Infectious Diseases. PMID 25995196 DOI: 10.1093/Infdis/Jiv296  0.592
2014 Peluso MJ, Spudich S. Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics. Current Hiv/Aids Reports. 11: 353-62. PMID 25063356 DOI: 10.1007/S11904-014-0223-Y  0.625
2013 Peluso MJ, Meyerhoff DJ, Price RW, Peterson J, Lee E, Young AC, Walter R, Fuchs D, Brew BJ, Cinque P, Robertson K, Hagberg L, Zetterberg H, Gisslén M, Spudich S. Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. The Journal of Infectious Diseases. 207: 1703-12. PMID 23460748 DOI: 10.1093/Infdis/Jit088  0.61
2012 Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, Gisslén M, Angoff N, Price RW, Cinque P, Spudich S. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. Aids (London, England). 26: 1765-74. PMID 22614889 DOI: 10.1097/Qad.0B013E328355E6B2  0.592
Show low-probability matches.